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abstRact 
IntroductIon: Fine-needle aspiration biopsy (FNAB) is the 
cornerstone of thyroid nodule evaluation. In most cases, 
FNAB can discriminate between benign and malignant dis-
ease. In other cases, it is only indicative of malignancy and 
the results are considered “suspicious”. In Denmark, thyroid 
FNAB results are categorised into six groups; “inadequate”, 
“cystic”, “inconclusive”, “benign”, “suspicious” and “malig-
nant”. The risk of malignancy in the Danish “suspicious” 
group is of interest for patients as well as doctors partici-
pating in the diagnosis and treatment. The Danish Thyroid 
Surgery Database (THYKIR) registers preoperative thyroid 
FNAB and final histology. The aim of this study was to as-
sess the malignancy risk among patients with a suspicious 
thyroid FNAB according to the Danish criteria and to iden-
tify possible predictors of malignant histology.
Methods: A prospective cohort counting 483 patients with 
a “suspicious” thyroid FNAB who had been treated surgic-
ally in The Region of Southern Denmark in the 2001-2013 
period was retrieved from the THYKIR database. 
results: The risk of malignancy in the Danish thyroid FNAB 
“suspicious” group is 22%. Serum thyroid-stimulating hor-
mone outside the normal range and vocal cord palsy may 
be patient-related predictors of malignancy. 
conclusIon: Awaiting the introduction of reliable tools  
for preoperative evaluation, the current practice with histo-
logical clarification of the “suspicious” thyroid FNAB seems 
justified.
FundIng: none.
trIal regIstratIon: not relevant.
Palpable thyroid nodules are frequent with a prevalence 
of 3-7% in the Western population [1]. Most nodules are 
benign, while approximately 5% are malignant [2]. Thyr-
oid carcinoma is the most common endocrine malig-
nancy in Europe [3]. The Danish Thyroid Cancer Database 
(DATHYRCA) had 327 patients registered with thyroid 
carcinoma in 2014 [4]. The population in Denmark is 5.6 
million. A recent Danish study showed that 67% of thyr-
oid carcinomas are of the papillary type, 18% of the fol-
licular type, 7% of the medullary type and 8% of the un-
differentiated (anaplastic) type. The same study reported 
a significant rise in the incidence of papillary thyroid car-
cinoma in Denmark from 1996 to 2008 [5].
Great efforts are aimed at providing a cost-effective 
diagnostic strategy for thyroid nodules in order to re-
duce unnecessary surgery. However, preoperative as-
sessment of thyroid nodules remains a diagnostic chal-
lenge [2]. Fine-needle aspiration biopsy (FNAB), often 
ultrasound (US)-guided, is a cornerstone in the evalu-
ation of the nodular thyroid lesion [6-8] due to its cost-
effectiveness and because it is an easily applicable 
method. A Danish study from 2012 investigated the di-
agnostic accuracy of US-guided FNAB in thyroid nodules 
and found a sensitivity for malignancy of 73.9% and a 
specificity of 99.2% [2]. The positive and negative predic-
tive values of thyroid FNAB for malignancy were 89.5% 
and 97.7%, respectively [2]. In most cases, thyroid FNAB 
provides a definitive diagnosis of a malignant or benign 
nodule. However, it was reported that in 10-42% of all 
nodules, a conclusive diagnosis cannot be obtained by 
FNAB alone [7-9].
Increasingly more centres use The Bethesda Clas-
sification System for Reporting Thyroid Cyto pathology 
[10]. In Denmark, thyroid cytology is categorised accord-
ing to the definition in the National Thyroid Surgery 
Database (THYKIR), in which Bethesda group III (atypia 
of undetermined significance or follicular lesion of un-
determined significance), group IV (follicular neoplasm 
or suspicious of follicular neoplasia) and group V (sus-
picious of malignancy) are merged in only one group 
named “suspicious” FNAB finding. In the literature, 
these Bethesda groups are variably included in the term 
“indeterminate” FNAB, with a reported risk of malig-
nancy ranging from 19% to 49% [11-14]. Data from the 
suspicious group from the THYKIR Database have never 
been published. Several studies have focused on iden-
tifying factors that may predict malignancy in thyroid 
nodules that have a “suspicious” cytology, but with vary-
ing results [2, 9, 11, 13, 15-17].
By 1 January 2009, a “cancer package solution” for 
patients with suspicion of head and neck cancer (HNC) 
was implemented in Denmark. This fast-track pro-
gramme includes pre-booked slots for diagnostic pro-
cedures, and it significantly reduces the waiting time for 
patients with suspicion of HNC [6]. Patients with a suspi-
cious thyroid FNAB are included in the programme, and 
lobectomy including exploration or dissection of ipsilat-
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eral level 6 is the procedure for most of these patients.  
If suspicious lymph nodes are detected during surgery, 
frozen-section histological analysis may be performed 
intraoperatively and the treatment is adjusted accord-
ingly [18]. 
The aim of this study was to calculate the frequency 
of malignancy in patients with a “suspicious” thyroid 
FNAB according to the Danish criteria, and to identify 
possible preoperative patient-related predictors of ma-
lignancy.
mEthOds 
This study is descriptive and based on a prospectively 
registered cohort. Patients with a “suspicious” thyroid 
FNAB who had thyroid surgery performed at the depart-
ments of otorhinolaryngology Head & Neck Surgery in 
the Region of Southern Denmark (Odense University 
Hospital, Vejle Hospital, Esbjerg Hospital and Soender-
borg Hospital) from 1 January 2001 to 31 December 
2013 were identified through the THYKIR database.  
Basic clinical parameters, cytology findings, surgical pro-
cedures and histology were analysed. In the THYKIR  
database, thyroid cytology is categorised as; “FNAB not 
performed”, “inadequate”, “cystic”, “inconclusive”, “be-
nign”, “suspicious”, “malignant” or “information miss-
ing”. Among 3,449 patients from the Region of Southern 
Denmark, 491 patients were identified with a suspicious 
thyroid FNAB. Eight patients were excluded due to in-
sufficient data concerning their histological diagnosis. 
The final study population consisted of 483 patients (Fig-
ure 1) of whom 374 (77%) were women. The median age 
was 53 years at the time of surgery. Data were stored 
and processed in EXCEL, and STATA (14/IC) was used for 
statistical analysis. Non-parametric statistic methods, 
primarily the chi2-test, were used. To identify potential 
predictive factors for malignant histology, selected pre-
operative variables were dichotomized and analysed 
(table 1). The level of significance was set to p < 0.05. 
The study was approved by the Danish Data Protection 
Agency/Region of Southern Denmark (r.no.:15/36370 
and 15/28871). All information was identified from an 
already approved database and no other patient records 
were used.
Trial registration: not relevant.
REsUlts
Frequency of malignancy
Malignant histology was found in 108 (22.4%) of the 483 
patients with a suspicious cytology. Thyroid-derived  
cancer was diagnosed in 98 (90.7%) patients, of which 
91.1% was papillary or follicular carcinoma. The remain-
ing ten patients (9.3%) were diagnosed with lymphoma, 
metastasis or other malignant histology (table 2).  
A total of 350 patients out of the 483 (72%) patients in-
cluded had a diagnostic thyroid scintigraphy performed. 
Of these, 279 (80%) had a focal hypo-functioning area  
(a “cold nodule”). The rest of the scintigraphy results 
were distributed as follows: normal thyroid uptake 12; 
diffuse uptake six; “hot” area five; alternating uptake 42; 
reduced or no uptake six. The pathologist was not rou-
tinely informed about this information before evaluation 
of the cytologies, but could access the information from 
the patient records at will. Dichotomized data are shown 
in Table 1.
Possible patient-related predictors of  
malignant histology
To identify possible factors capable of predicting malig-
nancy among patients with a suspicious thyroid FNAB, 
patient-related variables were analysed. The results are 
presented in Table 1. 
FigURE 1
Study population.
3,449 patients registered in the THYKIR database 
in the Region of Southern Denmark, from  
1 January 2001 to 31 December 2013
491 patients identified with 
“suspicious” FNAB
483 patients included in  
the study
8 patients excluded due to
insufficient data about their 
final histological diagnosis
FNAB = fine-needle aspiration biopsy; THYKIR = The Danish Thyroid Sur-
gery Database.
Fine-needle aspiration in clinical setup.
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discUssiOn
This study presents the frequency of malignancy among 
patients with suspicious thyroid FNAB according to the 
Danish criteria. The information is important for medical 
counselling of the thyroid nodule patient and therefore 
important for doctors in several specialties. We found a 
22.4% risk for malignancy when thyroid FNAB was “sus-
picious” according to the Danish criteria. Additionally, 
we found that malignancy was associated with serum 
thyroid-stimulating hormone (S-TSH) values outside the 
normal range and with dysfunctional vocal cords.
Previously, a Danish single-centre study reported a 
frequency of 20.5% [2]. Using the Bethesda classification 
system, the risk of malignancy of a thyroid nodule within 
group III, IV and V ranges from 5% to 75%, depending on 
the diagnostic subgroup [10]. The “indeterminate” cat-
egory of thyroid nodules includes atypia of undeter-
mined significance, follicular lesion of undetermined sig-
nificance, suspicious of follicular neoplasm, follicular 
neoplasm, and suspicious of malignancy [19]. This group 
is almost similar to the Danish “suspicious” group and 
previous studies have shown malignancy frequencies in  
the 19-49% range, which is comparable to our findings 
[11-14]. 
When comparing Danish and US thyroid FNAB re-
sults, differences in the occurrence of hyper-functioning 
thyroid nodules have to be taken into consideration. 
Denmark is a relatively iodine-deficient country, while 
the US has a high level of dietary iodine which explains 
this difference. Almost all hyper-functioning “hot”  
thyroid nodules are benign and should not routinely be  
investigated with thyroid FNAB. Therefore, information 
about scintigraphy is important in the diagnostic work-
up. 
Gene expression classifiers (panels of genetic muta-
tions and rearrangements) have recently been devel-
oped to discriminate between benign and malignant 
thyroid nodule FNABs. Studies indicate the potential for 
reduction of the number of patients having surgery due 
to an indeterminate FNAB [19]. The results seem prom-
ising, but the technique is expensive and currently com-
mercial genetic analysis has been implemented in rou-
tine diagnostic workup only at a limited number of 
centres. 
Longstanding hoarseness is a known red flag for 
malignancy [6], and - as expected - the risk of this was 
increased in the group of patients with impaired vocal 
cord mobility at the time of their diagnosis. However, 
the finding that S-TSH values outside the normal ranges 
should be an indicator of increased risk of malignancy 
among patients with a “suspicious” FNAB was surprising 
even though a systematic review and meta-analysis by 
McLeod et al [16] found that a higher serum TSH con-
centration is associated with higher odds of thyroid can-
cer, even within the normal TSH ranges. Other studies 
support this [15, 17]. In contrast hereto, Castro et al [13] 
found no association between S-TSH and risk of thyroid 
malignancy and it must be concluded that the literature 
seems weak and rather contradictory in this field. In our 
study, it was only registered if the S-TSH was inside or 
outside the reference level and we cannot contribute 
further to the discussion. However, our results do sug-
gest that abnormal levels of thyroid hormone may play a 
role as a predictor of thyroid carcinoma.
tablE 1
Factors possibly predictive of malignancy among patients with a “suspicious” thyroid fine-needle aspir-
ation biopsy.
dichotomization (n) n % n % p-value
Odds  
ratio
Agea NS NS
≥ 53.0 yrs (241)   62 25.7 179 74.3
< 53.0 yrs (242)   46 19.0 196 81.0
Sex NS NS
Female (374)   83 22.2 291 77.8
Male (109)   25 22.9   84 77.1
Ultrasound finding NS NS
Solitary solid tumour (232)   57 24.6 175 75.4
Other (240)   47 19.6 193 80.4
Serum stimulating thyroid hormone < 0.05 3.1
Outside normal ranges (22)   10 45.5   12 54.5
Inside normal ranges (456)   96 21.0 360 79.0
Vocal cord mobility < 0.01 8.9
Impaired or no mobility (7)     5 71.4     2 28.6
Normal mobility (468) 103 22.0 365 78.0
Earlier thyroid surgery NS NS
Yes (26)     9 34.6   17 65.4
No (456)   98 21.5 358 78.5
Earlier radioactive iodine treatmentb NS NS
Yes (6)     2 33.3     4 66.7
No (477) 106 22.2 371 77.8
Scintigraphic finding NS NS
“Cold nodule” (279)   50 14.3 229 65.5
Other (71)   11   3.1   60 17.1
NS = non-significant. 
a) Dichotomized at the median age of the patients at the time of surgery. 
b) Given before surgery on benign indication.
malignant histology benign histology
tablE 2
diagnosis n (%)
Papillary carcinoma 55 (50.9)
Follicular carcinoma 34 (31.5)
Medullary carcinoma   4 (3.7)
Undifferentiated carcinoma   5 (4.6)
Lymphoma   2 (1.9)
Metastasis   2 (1.9)
Other malignant histology   6 (5.6)
Distribution of malignant 
histological diagnoses 
among patients with a 
“suspicious” thyroid fine-
needle aspiration biopsy  
(N = 108). 
 4  da n i s h m E d i c a l J O U R n a l Dan Med J 64/2  February 2017
This study has limitations concerning data report-
ing. Data were accepted as reported and failures may 
occur. Due to the limited number of malignant cases, 
significant predictors of malignancy may have been 
overlooked. Further, the direct correlation between 
“suspicious” thyroid FNAB and histology may be uncer-
tain since the design of this study does not secure that 
the nodule biopsied is the same as the one containing a 
malignant diagnosis. The study is only able to evaluate 
the overall frequency of malignancy in the group of pa-
tients with a “suspicious” thyroid FNAB. 
The prospective design, the high completeness in 
the THYKIR database [20] and the coverage of a specific 
geographical referral area (Region of Southern Denmark) 
are strengths which reduce any risk of bias and increase 
the generalisability of results. 
cOnclUsiOn 
The risk of malignancy in the Danish thyroid FNAB “sus-
picious” group is 22% and S-TSH outside the normal 
range and vocal cord palsy may be patient-related pre-
dictors of malignancy. Awaiting the introduction of reli-
able tools for preoperative evaluation, current practice 
with histological clarification of the “suspicious” thyroid 
FNAB seems justified.
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